Birdwatch Note
2024-12-25 03:07:40 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
「インドで子宮頸がんワクチン（メルク社製）を１２０人の少女に接種し４人が死亡」 との主張は、インド政府の調査で否定されています。 死因が溺死やマラリアで、子宮頸がんワクチン接種とは無関係です https://www.icmr.gov.in/icmrobject/static/icmr/dist/images/pdf/reports/HPV_PATH_final_report.pdf
Written by BFFA3FF9DA5EBAF072AE80CC9C7256B14822D1F0AFF08E9F2E49E3EBA95A4284
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1871352698790097017
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1871754656663400767
- noteId - 1871754656663400767
- participantId -
- noteAuthorParticipantId - BFFA3FF9DA5EBAF072AE80CC9C7256B14822D1F0AFF08E9F2E49E3EBA95A4284 Participant Details
- createdAtMillis - 1735096060325
- tweetId - 1871352698790097017
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 「インドで子宮頸がんワクチン（メルク社製）を１２０人の少女に接種し４人が死亡」 との主張は、インド政府の調査で否定されています。 死因が溺死やマラリアで、子宮頸がんワクチン接種とは無関係です https://www.icmr.gov.in/icmrobject/static/icmr/dist/images/pdf/reports/HPV_PATH_final_report.pdf
Note Ratings
| rated at | rated by | |
| 2024-12-24 21:50:12 -0600 | Rating Details | |
| 2024-12-24 21:12:40 -0600 | Rating Details | |
| 2024-12-31 06:01:14 -0600 | Rating Details | |
| 2024-12-25 22:54:29 -0600 | Rating Details | |
| 2024-12-24 21:41:50 -0600 | Rating Details |